Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7098 results

Takeda gains exclusive rights to Amitiza beyond US and Canada

23-10-2014

US biopharma company Sucampo Pharmaceuticals saw its shares rise 5.6% to $8.46 in morning trading, after…

AmitizaGastro-intestinalsGlobalLicensingPharmaceuticalSucampoTakeda Pharmaceutical

Lilly expands collaboration with Zymeworks

Lilly expands collaboration with Zymeworks

23-10-2014

US pharma major Eli Lilly and privately-held Canadian biotech firm Zymeworks have expanded their existing…

CanadaEli LillyLicensingOncologyPharmaceuticalResearchUSAZymeworks

Ferring Pharma’s Cortiment gains EU approval

Ferring Pharma’s Cortiment gains EU approval

23-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says its Cortiment (budesonide) treatment…

CortimentCosmo PharmaceuticalsEuropeFerring PharmaceuticalsGastro-intestinalsPentasaPharmaceuticalRegulation

EMA moves further to push Ebola treatments development

EMA moves further to push Ebola treatments development

23-10-2014

During the past months, the European Medicines Agency has put in place a system to give the best possible…

Anti-viralsEuropePharmaceuticalRegulationResearchVaccines

Cost of Australian PBS rises below rate of inflation for 2013-2014

Cost of Australian PBS rises below rate of inflation for 2013-2014

23-10-2014

The Australian Department of Health has confirmed that growth of the Pharmaceutical Benefits Scheme cost…

AustraliaMedicines AustraliaPharmaceuticalPharmaceuticals policyRegulation

Partnership led by UK Medical Research Council to invest more than $368 million in medical technology

Partnership led by UK Medical Research Council to invest more than $368 million in medical technology

23-10-2014

The UK’s chancellor of the exchequer, George Osborne, has announced that a partnership led by the Medical…

PharmaceuticalResearchUKUnited KingdomWELLCOME TRUST

UK’s NICE backs another use for Bayer’s Xarelto

UK’s NICE backs another use for Bayer’s Xarelto

23-10-2014

In draft guidance published today for consultation, the UK’s health costs watchdog the National Institute…

BayerCardio-vascularPharmaceuticalPricingRegulationUKXarelto

Abbott raises midpoint of EPS guidance and sees shares rise as quarterly profit exceeds forecast

Abbott raises midpoint of EPS guidance and sees shares rise as quarterly profit exceeds forecast

22-10-2014

Shares of US health care company Abbott Laboratories rose slightly in the premarket trading period following…

Abbott LaboratoriesFinancialPharmaceuticalUnited StatesUSA

GlaxoSmithKline’s third-qtr results not as bad as expected

GlaxoSmithKline’s third-qtr results not as bad as expected

22-10-2014

UK pharma giant GlaxoSmithKline has reported a downturn in both sales and profits for the third quarter…

FinancialGlaxoSmithKlinePharmaceuticalThomson ReutersUKViiV Healthcare

Tekmira starts manufacture of new RNAi therapeutic for Ebola

Tekmira starts manufacture of new RNAi therapeutic for Ebola

22-10-2014

Canadian RNA interference (RNAi) therapeutics developer Tekmira Pharmaceuticals says it has commenced…

Anti-viralsCanadaPharmaceuticalProductionResearchTekmira PharmaceuticalsTKM-Ebola

GW Pharmaceuticals granted orphan designation by the EMA for Epidiolex

GW Pharmaceuticals granted orphan designation by the EMA for Epidiolex

22-10-2014

Cannabinoid product specialist GW Pharmaceuticals has been granted orphan designation by the European…

CNS DiseasesepidiolexGW PharmaceuticalsPharmaceuticalResearchUSA

Actavis signs option to acquire relamorelin developer

Actavis signs option to acquire relamorelin developer

22-10-2014

Ireland-headquartered Actavis has been granted an exclusive option to acquire USA-based biopharma company…

ActavisDiabetesGastro-intestinalsIrelandMergers & AcquisitionsPharmaceuticalrelamorelinRhythm Health

New angel investment initiative to boost funding for UK bioscience businesses

New angel investment initiative to boost funding for UK bioscience businesses

22-10-2014

Emerging bioscience companies in the UK will have access to new sources of funding as a result of an…

FinancialLondon Business AngelsPharmaceuticalUKUnited Kingdom

Ferring Pharma regains rights to DDAVP portfolio

Ferring Pharma regains rights to DDAVP portfolio

22-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says it has acquired DDAVP (desmopressin…

DDAVPDiabetesFerring PharmaceuticalsGenito-urinaryLicensingPharmaceuticalSanofiSwitzerland

Roche to invest billions in new R&D facility and Basel updates

Roche to invest billions in new R&D facility and Basel updates

22-10-2014

Swiss pharma major Roche says it will invest 3 billion Swiss francs ($3.2 billion) in new research infrastructure…

FinancialGeography of EuropePharmaceuticalRocheSwitzerland

Ipsen to commercialize Lexicon carcinoid drug ex-North America/Japan

22-10-2014

French drugmaker Ipsen has entered into an accord with Lexicon Pharmaceuticals to commercialize the US…

EuropeIpsenLexicon PharmaceuticalsLicensingOncologyPharmaceuticaltelotristat etiprate

NICE recommends another new skin cancer drug, GSK’s Tafinlar

22-10-2014

The UK National Institute for Health and Care Excellence (NICE) has issued final guidance recommending…

GlaxoSmithKlineOncologyPharmaceuticalPricingRegulationTafinlarUK

IQWiG finds no added benefit for GSK’s Anoro Ellipta in COPD

21-10-2014

According to the findings of an early benefit assessment under the German Act on the Reform of the Market…

Anoro ElliptaGermanyGlaxoSmithKlinePharmaceuticalPricingRegulationRespiratory and Pulmonary

Reckitt Benckiser Pharmaceuticals demerges from group and rebrands as Indivior

Reckitt Benckiser Pharmaceuticals demerges from group and rebrands as Indivior

21-10-2014

US-based pharma company Reckitt Benckiser Pharmaceuticals announced that its UK-based parent company,…

Business FinancePharmaceuticalReckitt BenckiserReckitt Benckiser PharmaceuticalsUSA

EMA urging firms with Ebola candidates to seek orphan status

21-10-2014

The European Medicines Agency is aiming to encourage developers of treatments or vaccines against Ebola…

Anti-viralsEuropePharmaceuticalRare diseasesRegulationResearchUSA

Fujifilm starts production of Avigan for the treatment of Ebola

21-10-2014

Japan’s Fujifilm says it has decided to start production of the anti-influenza drug Avigan (favipiravir)…

Anti-viralsAviganFujifilmPharmaceuticalProductionResearchToyama

Currency restrictions may result in collapse of Ukrainian pharmaceutical market

21-10-2014

Leading Ukrainian pharmaceutical producers and importers have sent an official letter to the national…

FinancialPharmaceuticalPoliticsUkraine

1 to 25 of 7098 results

Back to top